Mary Bordeaux is an independent consultant with offices in San Francisco, CA. Her practice, Mary Bordeaux Consulting, was established in 2002 with a focus on coverage / reimbursement / distribution strategies for small and emerging pharmaceutical / biotech companies and emerging technologies. She has over 30 years in the pharmaceutical industry. Client projects span the development, acquisition, and commercialization phases of company and product life cycles. A major focus of her practice is market research and advisory projects involving the payer community. Her client base is throughout the U.S. Her last industry position was as Vice President of Health Systems for ALZA Corporation. Previous to ALZA, Mary was with VIVUS Pharmaceuticals and Syntex.
The presentation will explore the changes in health care access codified by the recently enacted health care reform legislation. Mary Bordeaux has a unique view into the payer and drug manufacturer perspective through her consulting practice and will highlight some of the cost and administration issues these stakeholders now face in providing expanded access to U.S. consumers. Changes in consumer access will focus on all age groups including seniors, workers of all income levels, young adults and children. We’ve all heard what health care reform is supposed to do…we’ll now learn what is likely required to make some of the more important elements happen.
